Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
9.4
4.8
Journals
Biomolecules
Special Issues
Dysregulation of Calcium Signaling in Pathological Processes
share announcement

Dysregulation of Calcium Signaling in Pathological Processes

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".

Deadline for manuscript submissions: 30 November 2024 | Viewed by 11386

Special Issue Editor

Prof. Dr. Antonio Villalobo

E-Mail Website1 Website2
Guest Editor
Instituto de Investigaciones Sanitarias (IdiPAZ), Hospital Universitario La Paz, Madrid, Spain
Interests: calcium; calmodulin; cancer; receptor tyrosine kinases EGFR/ErbB1/HER1 and ErbB2/HER2; adaptor protein Grb7; and non-receptor tyrosine kinase Src
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Calcium-mediated signaling in eukaryotic cells is an universal mechanism controlling a myriad of cellular processes. In a significant number of human pathologies, the dysregulation of Ca2+ signaling and Ca2+-mediated control systems implicated in diverse cellular functions have been observed. This Special Issue collects reviews and research articles describing a variety of alterations in human pathologies occurring in the toolkit used by the cells to handle Ca2+ signaling, including potentially important and already observed or newly suspected dysregulations of Ca2+ signaling in the followings illnesses, among others: cardiovascular diseases (e.g., heart arrhythmias and hypertrophy); muscle diseases (e.g., muscular dystrophies); neurodegenerative processes (e.g., Alzheimer disease, amyotrophic lateral sclerosis, Friedreich ataxia, Huntington disease, Lewy body dementia, frontotemporal dementia, Parkinson disease, and spinal muscular atrophy, among others); endocrine diseases (e.g., diabetes, and hypothalamus, pituitary, thyroid, adrenal, and other endocrine glands disorders); autoimmune diseases (e.g., multiple sclerosis, lupus erythematosus, Graves disease, among many others); and solid tumors and hematological cancers (leukemias and lymphomas). Finally, it will also consider diseases associated with failure in mitochondrial Ca2+ movement (e.g., Ca2+ uniport channel mutations); mutations of Ca2+-binding proteins (e.g., CaM, resulting in so-called calmodulinopathies, and troponin C, resulting in hypertrophic cardiomyopathies); mutations of Ca2+ channels (resulting in so-called channelopathies); and mutations of Ca2+ transporters (e.g., sarcoplasmic reticulum Ca2+-ATPase [SERCA], resulting in Darier disease, and plasma membrane Ca2+-ATPase [PMCA], resulting in Hailey–Hailey disease).

Kind regards,

Prof. Dr. Antonio Villalobo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Ca2+-ATPases
  • calmodulinopathies
  • cancer
  • cardiovascular diseases
  • channelopathies
  • endocrine diseases
  • mitochondrial diseases
  • muscle diseases
  • neurodegenerative diseases
  • troponin C

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (5 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Review

20 pages, 2940 KiB  
Review
Unmasking the Mechanism behind Miltefosine: Revealing the Disruption of Intracellular Ca2+ Homeostasis as a Rational Therapeutic Target in Leishmaniasis and Chagas Disease
by Gustavo Benaim and Alberto Paniz-Mondolfi
Biomolecules 2024, 14(4), 406; https://doi.org/10.3390/biom14040406 - 27 Mar 2024
Cited by 3 | Viewed by 2275
Abstract
Originally developed as a chemotherapeutic agent, miltefosine (hexadecylphosphocholine) is an inhibitor of phosphatidylcholine synthesis with proven antiparasitic effects. It is the only oral drug approved for the treatment of Leishmaniasis and American Trypanosomiasis (Chagas disease). Although its precise mechanisms are not yet fully [...] Read more.
Originally developed as a chemotherapeutic agent, miltefosine (hexadecylphosphocholine) is an inhibitor of phosphatidylcholine synthesis with proven antiparasitic effects. It is the only oral drug approved for the treatment of Leishmaniasis and American Trypanosomiasis (Chagas disease). Although its precise mechanisms are not yet fully understood, miltefosine exhibits broad-spectrum anti-parasitic effects primarily by disrupting the intracellular Ca2+ homeostasis of the parasites while sparing the human hosts. In addition to its inhibitory effects on phosphatidylcholine synthesis and cytochrome c oxidase, miltefosine has been found to affect the unique giant mitochondria and the acidocalcisomes of parasites. Both of these crucial organelles are involved in Ca2+ regulation. Furthermore, miltefosine has the ability to activate a specific parasite Ca2+ channel that responds to sphingosine, which is different to its L-type VGCC human ortholog. Here, we aimed to provide an overview of recent advancements of the anti-parasitic mechanisms of miltefosine. We also explored its multiple molecular targets and investigated how its pleiotropic effects translate into a rational therapeutic approach for patients afflicted by Leishmaniasis and American Trypanosomiasis. Notably, miltefosine’s therapeutic effect extends beyond its impact on the parasite to also positively affect the host’s immune system. These findings enhance our understanding on its multi-targeted mechanism of action. Overall, this review sheds light on the intricate molecular actions of miltefosine, highlighting its potential as a promising therapeutic option against these debilitating parasitic diseases. Full article
(This article belongs to the Special Issue Dysregulation of Calcium Signaling in Pathological Processes)
►▼ Show Figures

Figure 1

22 pages, 1241 KiB  
Review
Calcium-Associated Proteins in Neuroregeneration
by Malwina Lisek, Julia Tomczak, Tomasz Boczek and Ludmila Zylinska
Biomolecules 2024, 14(2), 183; https://doi.org/10.3390/biom14020183 - 2 Feb 2024
Cited by 2 | Viewed by 2159
Abstract
The dysregulation of intracellular calcium levels is a critical factor in neurodegeneration, leading to the aberrant activation of calcium-dependent processes and, ultimately, cell death. Ca2+ signals vary in magnitude, duration, and the type of neuron affected. A moderate Ca2+ concentration can [...] Read more.
The dysregulation of intracellular calcium levels is a critical factor in neurodegeneration, leading to the aberrant activation of calcium-dependent processes and, ultimately, cell death. Ca2+ signals vary in magnitude, duration, and the type of neuron affected. A moderate Ca2+ concentration can initiate certain cellular repair pathways and promote neuroregeneration. While the peripheral nervous system exhibits an intrinsic regenerative capability, the central nervous system has limited self-repair potential. There is evidence that significant variations exist in evoked calcium responses and axonal regeneration among neurons, and individual differences in regenerative capacity are apparent even within the same type of neurons. Furthermore, some studies have shown that neuronal activity could serve as a potent regulator of this process. The spatio-temporal patterns of calcium dynamics are intricately controlled by a variety of proteins, including channels, ion pumps, enzymes, and various calcium-binding proteins, each of which can exert either positive or negative effects on neural repair, depending on the cellular context. In this concise review, we focus on several calcium-associated proteins such as CaM kinase II, GAP-43, oncomodulin, caldendrin, calneuron, and NCS-1 in order to elaborate on their roles in the intrinsic mechanisms governing neuronal regeneration following traumatic damage processes. Full article
(This article belongs to the Special Issue Dysregulation of Calcium Signaling in Pathological Processes)
►▼ Show Figures

Graphical abstract

20 pages, 1473 KiB  
Review
The Complex Interplay between Toxic Hallmark Proteins, Calmodulin-Binding Proteins, Ion Channels, and Receptors Involved in Calcium Dyshomeostasis in Neurodegeneration
by Danton H. O’Day
Biomolecules 2024, 14(2), 173; https://doi.org/10.3390/biom14020173 - 31 Jan 2024
Cited by 3 | Viewed by 1769
Abstract
Calcium dyshomeostasis is an early critical event in neurodegeneration as exemplified by Alzheimer’s (AD), Huntington’s (HD) and Parkinson’s (PD) diseases. Neuronal calcium homeostasis is maintained by a diversity of ion channels, buffers, calcium-binding protein effectors, and intracellular storage in the endoplasmic reticulum, mitochondria, [...] Read more.
Calcium dyshomeostasis is an early critical event in neurodegeneration as exemplified by Alzheimer’s (AD), Huntington’s (HD) and Parkinson’s (PD) diseases. Neuronal calcium homeostasis is maintained by a diversity of ion channels, buffers, calcium-binding protein effectors, and intracellular storage in the endoplasmic reticulum, mitochondria, and lysosomes. The function of these components and compartments is impacted by the toxic hallmark proteins of AD (amyloid beta and Tau), HD (huntingtin) and PD (alpha-synuclein) as well as by interactions with downstream calcium-binding proteins, especially calmodulin. Each of the toxic hallmark proteins (amyloid beta, Tau, huntingtin, and alpha-synuclein) binds to calmodulin. Multiple channels and receptors involved in calcium homeostasis and dysregulation also bind to and are regulated by calmodulin. The primary goal of this review is to show the complexity of these interactions and how they can impact research and the search for therapies. A secondary goal is to suggest that therapeutic targets downstream from calcium dyshomeostasis may offer greater opportunities for success. Full article
(This article belongs to the Special Issue Dysregulation of Calcium Signaling in Pathological Processes)
►▼ Show Figures

Figure 1

24 pages, 7675 KiB  
Review
Ca2+ Signaling and Src Functions in Tumor Cells
by Antonio Villalobo
Biomolecules 2023, 13(12), 1739; https://doi.org/10.3390/biom13121739 - 3 Dec 2023
Cited by 1 | Viewed by 2191
Abstract
Signaling by calcium ion (Ca2+) plays a prominent role in cell physiology, and these mechanisms are frequently altered in tumor cells. In this review, we consider the interplay of Ca2+ signaling and the functions of the proto-oncogene non-receptor tyrosine kinase [...] Read more.
Signaling by calcium ion (Ca2+) plays a prominent role in cell physiology, and these mechanisms are frequently altered in tumor cells. In this review, we consider the interplay of Ca2+ signaling and the functions of the proto-oncogene non-receptor tyrosine kinase c-Src in tumor cells, and the viral oncogenic variant v-Src in transformed cells. Also, other members of the Src-family kinases are considered in this context. The role of Ca2+ in the cell is frequently mediated by Ca2+-binding proteins, where the Ca2+-sensor protein calmodulin (CaM) plays a prominent, essential role in many cellular signaling pathways. Thus, we cover the available information on the role and direct interaction of CaM with c-Src and v-Src in cancerous cells, the phosphorylation of CaM by v-Src/c-Src, and the actions of different CaM-regulated Ser/Thr-protein kinases and the CaM-dependent phosphatase calcineurin on v-Src/c-Src. Finally, we mention some clinical implications of these systems to identify mechanisms that could be targeted for the therapeutic treatment of human cancers. Full article
(This article belongs to the Special Issue Dysregulation of Calcium Signaling in Pathological Processes)
►▼ Show Figures

Figure 1

14 pages, 849 KiB  
Review
The Ca2+ Sensor STIM in Human Diseases
by Alejandro Berna-Erro, Jose Sanchez-Collado, Joel Nieto-Felipe, Alvaro Macias-Diaz, Pedro C. Redondo, Tarik Smani, Jose J. Lopez, Isaac Jardin and Juan A. Rosado
Biomolecules 2023, 13(9), 1284; https://doi.org/10.3390/biom13091284 - 22 Aug 2023
Cited by 5 | Viewed by 2083
Abstract
The STIM family of proteins plays a crucial role in a plethora of cellular functions through the regulation of store-operated Ca2+ entry (SOCE) and, thus, intracellular calcium homeostasis. The two members of the mammalian STIM family, STIM1 and STIM2, are transmembrane proteins [...] Read more.
The STIM family of proteins plays a crucial role in a plethora of cellular functions through the regulation of store-operated Ca2+ entry (SOCE) and, thus, intracellular calcium homeostasis. The two members of the mammalian STIM family, STIM1 and STIM2, are transmembrane proteins that act as Ca2+ sensors in the endoplasmic reticulum (ER) and, upon Ca2+ store discharge, interact with and activate the Orai/CRACs in the plasma membrane. Dysregulation of Ca2+ signaling leads to the pathogenesis of a variety of human diseases, including neurodegenerative disorders, cardiovascular diseases, cancer, and immune disorders. Therefore, understanding the mechanisms underlying Ca2+ signaling pathways is crucial for developing therapeutic strategies targeting these diseases. This review focuses on several rare conditions associated with STIM1 mutations that lead to either gain- or loss-of-function, characterized by myopathy, hematological and immunological disorders, among others, and due to abnormal activation of CRACs. In addition, we summarize the current evidence concerning STIM2 allele duplication and deletion associated with language, intellectual, and developmental delay, recurrent pulmonary infections, microcephaly, facial dimorphism, limb anomalies, hypogonadism, and congenital heart defects. Full article
(This article belongs to the Special Issue Dysregulation of Calcium Signaling in Pathological Processes)
►▼ Show Figures

Graphical abstract

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-5

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

Title: To be determined
Authors: Kasope Wolffs
Affiliation: College of Biomedical and Life Sciences
Abstract: To be determined

Title: To be determined
Authors: Cano Raquel
Affiliation: Departamento de Fisiología Médica y Biofísica, Universidad de Sevilla
Abstract: To be determined

Back to TopTop